Because the PTEN/AKT signaling pathways adjust malignant behaviors and is frequently initiated in cancers embracing ESCC [18], we examined the relationship between Bin1 methylation and the key molecules of this signaling pathway by using immunoblotting studies. This evidence concerns the gene BIN1 and esophageal squamous cell carcinoma.